Xuesi Wan1,2, James Perry1, Haichen Zhang1, Feng Jin1, Kathleen A Ryan1, Cristopher Van Hout3, Jeffrey Reid3, John Overton3, Aris Baras3, Zhe Han1, Elizabeth Streeten1, Yanbing Li2, Braxton D Mitchell1, Alan R Shuldiner4, Mao Fu5. 1. Program in Personalized and Genomic Medicine, Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland. 2. Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. 3. Regeneron Genetics Center, Tarrytown, New York. 4. Regeneron Genetics Center, Tarrytown, New York alan.shuldiner@regeneron.com maofu001@gmail.com. 5. Program in Personalized and Genomic Medicine, Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland alan.shuldiner@regeneron.com maofu001@gmail.com.
Abstract
BACKGROUND: Potassium levels regulate multiple physiologic processes. The heritability of serum potassium level is moderate, with published estimates varying from 17% to 60%, suggesting genetic influences. However, the genetic determinants of potassium levels are not generally known. METHODS: A whole-exome sequencing association study of serum potassium levels in 5812 subjects of the Old Order Amish was performed. A dietary salt intervention in 533 Amish subjects estimated interaction between p.R642G and sodium intake. RESULTS: A cluster of variants, spanning approximately 537 kb on chromosome 16q13, was significantly associated with serum potassium levels. Among the associated variants, a known pathogenic variant of autosomal recessive Gitelman syndrome (p.R642G SLC12A3) was most likely causal; there were no homozygotes in our sample. Heterozygosity for p.R642G was also associated with lower chloride levels, but not with sodium levels. Notably, p.R642G showed a novel association with lower serum BUN levels. Heterozygotes for p.R642G had a two-fold higher rate of self-reported bone fractures and had higher resting heart rates on a low-salt diet compared with noncarriers. CONCLUSIONS: This study provides evidence that heterozygosity for a pathogenic variant in SLC12A3 causing Gitelman syndrome, a canonically recessive disorder, contributes to serum potassium concentration. The findings provide insights into SLC12A3 biology and the effects of heterozygosity on electrolyte homeostasis and related subclinical phenotypes that may have implications for personalized medicine and nutrition.
BACKGROUND: Potassium levels regulate multiple physiologic processes. The heritability of serum potassium level is moderate, with published estimates varying from 17% to 60%, suggesting genetic influences. However, the genetic determinants of potassium levels are not generally known. METHODS: A whole-exome sequencing association study of serum potassium levels in 5812 subjects of the Old Order Amish was performed. A dietary salt intervention in 533 Amish subjects estimated interaction between p.R642G and sodium intake. RESULTS: A cluster of variants, spanning approximately 537 kb on chromosome 16q13, was significantly associated with serum potassium levels. Among the associated variants, a known pathogenic variant of autosomal recessive Gitelman syndrome (p.R642G SLC12A3) was most likely causal; there were no homozygotes in our sample. Heterozygosity for p.R642G was also associated with lower chloride levels, but not with sodium levels. Notably, p.R642G showed a novel association with lower serum BUN levels. Heterozygotes for p.R642G had a two-fold higher rate of self-reported bone fractures and had higher resting heart rates on a low-salt diet compared with noncarriers. CONCLUSIONS: This study provides evidence that heterozygosity for a pathogenic variant in SLC12A3 causing Gitelman syndrome, a canonically recessive disorder, contributes to serum potassium concentration. The findings provide insights into SLC12A3 biology and the effects of heterozygosity on electrolyte homeostasis and related subclinical phenotypes that may have implications for personalized medicine and nutrition.
Authors: Braxton D Mitchell; Patrick F McArdle; Haiqing Shen; Evadnie Rampersaud; Toni I Pollin; Lawrence F Bielak; Cashell Jaquish; Julie A Douglas; Marie-Hélène Roy-Gagnon; Paul Sack; Rosalie Naglieri; Scott Hines; Richard B Horenstein; Yen-Pei C Chang; Wendy Post; Kathleen A Ryan; Nga Hong Brereton; Ruth E Pakyz; John Sorkin; Coleen M Damcott; Jeffrey R O'Connell; Charles Mangano; Mary Corretti; Robert Vogel; William Herzog; Matthew R Weir; Patricia A Peyser; Alan R Shuldiner Journal: Am Heart J Date: 2008-03-05 Impact factor: 4.749
Authors: Andrew S Terker; Chong Zhang; James A McCormick; Rebecca A Lazelle; Chengbiao Zhang; Nicholas P Meermeier; Dominic A Siler; Hae J Park; Yi Fu; David M Cohen; Alan M Weinstein; Wen-Hui Wang; Chao-Ling Yang; David H Ellison Journal: Cell Metab Date: 2015-01-06 Impact factor: 27.287
Authors: Elizabeth A Streeten; Daniel J McBride; Toni I Pollin; Kathy Ryan; Jay Shapiro; Sandy Ott; Braxton D Mitchell; Alan R Shuldiner; Jeffery R O'Connell Journal: J Bone Miner Res Date: 2006-09 Impact factor: 6.741
Authors: Tamra E Meyer; Germaine C Verwoert; Shih-Jen Hwang; Nicole L Glazer; Albert V Smith; Frank J A van Rooij; Georg B Ehret; Eric Boerwinkle; Janine F Felix; Tennille S Leak; Tamara B Harris; Qiong Yang; Abbas Dehghan; Thor Aspelund; Ronit Katz; Georg Homuth; Thomas Kocher; Rainer Rettig; Janina S Ried; Christian Gieger; Hanna Prucha; Arne Pfeufer; Thomas Meitinger; Josef Coresh; Albert Hofman; Mark J Sarnak; Yii-Der Ida Chen; André G Uitterlinden; Aravinda Chakravarti; Bruce M Psaty; Cornelia M van Duijn; W H Linda Kao; Jacqueline C M Witteman; Vilmundur Gudnason; David S Siscovick; Caroline S Fox; Anna Köttgen Journal: PLoS Genet Date: 2010-08-05 Impact factor: 5.917
Authors: Frederick E Dewey; Viktoria Gusarova; Colm O'Dushlaine; Omri Gottesman; Jesus Trejos; Charleen Hunt; Cristopher V Van Hout; Lukas Habegger; David Buckler; Ka-Man V Lai; Joseph B Leader; Michael F Murray; Marylyn D Ritchie; H Lester Kirchner; David H Ledbetter; John Penn; Alexander Lopez; Ingrid B Borecki; John D Overton; Jeffrey G Reid; David J Carey; Andrew J Murphy; George D Yancopoulos; Aris Baras; Jesper Gromada; Alan R Shuldiner Journal: N Engl J Med Date: 2016-03-02 Impact factor: 91.245
Authors: Ryan N Doan; Elaine T Lim; Silvia De Rubeis; Catalina Betancur; David J Cutler; Andreas G Chiocchetti; Lynne M Overman; Aubrie Soucy; Susanne Goetze; Christine M Freitag; Mark J Daly; Christopher A Walsh; Joseph D Buxbaum; Timothy W Yu Journal: Nat Genet Date: 2019-06-17 Impact factor: 38.330